Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Also known as: Dept. of Neurology, INNSZ | INCMNSZ | INCMNSZ / IBB UNAM | Instituto Nacional De Ciencias Médicas y Nutrición | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran | Instituto Nacional de Ciencias Medicas y Nutricio Salvador Zurbaran, Mexico | JOSE MANUEL ARREOLA GUERRA | Luis Eduardo Morales Buenrostro | National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Highest phase reached
Phase 4
First clinical trial
Nov 1, 1997Last known activity
May 7, 2025
Timeline
1940s
- Jan 1, 1946
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran— Founded
Drugs by trial phase (88 distinct, 74 trials)
Phase 4 (25 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (33 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Kidney Injury
- Acute Lung Injury
- Albuminuria
- Ascites
- Bacteriuria
- Brain Diseases
- Breast Neoplasms
- Cardiovascular Diseases
- Coinfection
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Congenital Abnormalities
- Delirium
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Diabetic Nephropathies
- Fatty Liver
- Fibrosis
- Foot Ulcer
- Glucose Intolerance
- Hepatic Encephalopathy
- HIV Infections
- Hyperglycemia
- Hyperlipidemia, Familial Combined
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertension
- Hypoglycemia
- Hypokinesia
- Immunologic Deficiency Syndromes
- Infections
- Inflammation
- Inflammatory Bowel Diseases
- Kidney Diseases
- Kidney Failure, Chronic
- Latent Tuberculosis
- Leukemia
- Leukemia, Lymphoid
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Liver Diseases
- Lupus Erythematosus, Systemic
- Lymphopenia
- Neoplasm, Residual
- Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prediabetic State
- Pulmonary Fibrosis
- Renal Insufficiency
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- T-Lymphocytopenia, Idiopathic CD4-Positive
- Triple Negative Breast Neoplasms
- Tuberculosis
- Ulcer
- Urinary Tract Infections
- Uterine Cervical Neoplasms
- Vascular Calcification
- Vitamin D Deficiency
- Wounds and Injuries
Recent trials (50)
- NCT07018622Lead sponsorPhase 2May 7, 2025
- NCT07018622OfficialPhase 2May 7, 2025
- NCT06380491Sponsor investigatorPhase 4Jun 22, 2023
- NCT06380491Lead sponsorPhase 4Jun 22, 2023
- NCT06094894Reponsible party - principal investigatorN/AJun 1, 2023
- NCT06094894Lead sponsorN/AJun 1, 2023
- NCT06449170Sponsor investigatorN/AJan 1, 2023
- NCT05713851Reponsible party - principal investigatorPhase 2/Phase 3Jan 1, 2023
- NCT05713851Lead sponsorPhase 2/Phase 3Jan 1, 2023
- NCT06449170Lead sponsorN/AJan 1, 2023
- NCT05713851Sponsor investigatorPhase 2/Phase 3Jan 1, 2023
- NCT05584371Overall official - principal investigatorN/AOct 31, 2022
- NCT05584371Lead sponsorN/AOct 31, 2022
- NCT05318898Reponsible party - principal investigatorN/AMar 1, 2022
- NCT05318898Lead sponsorN/AMar 1, 2022
Details
- Founded
- Mexico City, MX Jan 1, 1946
- Last known activity
- May 7, 2025